MeridianHealth Achieves NCQA Commendable Accreditation Status for High-Quality Performance
This status was awarded to MeridianHealth for service and clinical quality that meet
"We are extremely happy to announce MeridianHealth sustained our Commendable Accreditation Status from
NCQA Health Plan Accreditation evaluates how well a health plan manages all parts of its delivery system – physicians, hospitals, other providers and administrative services – to continuously improve the quality of care and services provided to its members.
In addition to a Commendable Accreditation Status,
About Meridian:
Meridian is a family-owned, family-operated group of health plans with offices in
About
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/meridianhealth-achieves-ncqa-commendable-accreditation-status-for-high-quality-performance-300418386.html
SOURCE MeridianHealth


What Influences Your Auto Insurance Rates and How to Keep Premiums Low
Seven Safety Tips To Keep You Safe During Spring Break
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
- EIOPA FLAGS FINANCIAL STABILITY RISKS RELATED TO PRIVATE CREDIT, A WEAKENING DOLLAR AND GLOBAL INTERCONNECTEDNESS
- Envela partnership expands agent toolkit with health screenings
More Life Insurance News